Methods for treating Crohn's disease with specific anti-IL23 antibody

ES3073131T3Undetermined Publication Date: 2026-07-08JANSSEN BIOTECH INC (100 00)
View PDF 0 Cites 0 Cited by

Patent Information

Authority / Receiving Office
ES · ES
Patent Type
Patents
Current Assignee / Owner
JANSSEN BIOTECH INC (100 00)
Filing Date
2022-10-27
Publication Date
2026-07-08

Smart Images

  • Figure 00000049_0000
    Figure 00000049_0000
  • Figure 00000050_0000
    Figure 00000050_0000
Patent Text Reader

Abstract

One method for treating Crohn's disease in a patient involves administering a specific antibody against IL-23, for example, guselkumab, in an initial subcutaneous dose and subsequent subcutaneous doses so that the patient responds to the antibody and meets one or more of the clinical objectives.
Need to check novelty before this filing date? Find Prior Art